← Open Payments lookup

DEAN HAR: Open Payments

NPI 1104857150 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,443 in 31 payments from 8 companies in 2025. Trend: 2023 $1,832 · 2024 $2,268 · 2025 $1,443

Food & beverage: $1,443
CompanyPaymentsAmount
Lilly USA, LLC14$470
AstraZeneca Pharmaceuticals LP9$296
ABBVIE INC.2$226
Amgen Inc.1$125
Novo Nordisk Inc1$125
ARS Pharmaceuticals Operations, Inc.1$125
Boehringer Ingelheim Pharmaceuticals, Inc.2$60
PFIZER INC.1$17

Products named: JARDIANCE, VRAYLAR, FARXIGA, Repatha, Ozempic, NEFFY, ZEPBOUND, BREZTRI.

Industry payments across CT — which companies pay providers there.